Herein, the correlation between the expression of tumor-associated macrophages CD86, CD206, and PD-L1 in hepatocellular carcinoma and clinicopathology was analyzed, and their clinical application value in the prognosis assessment of patients was highlighted. This evidence concerns the gene MRC1 and hepatocellular carcinoma.